Ultimovacs ASA (ULTI) — Financial Flexibility Index
Ultimovacs ASA (ULTI) has a Financial Flexibility Index of -0.74x as of December 2024. Free cash flow of Nkr-24.70 Million (operating CF Nkr-24.70 Million minus capex Nkr0.00) represents -1% of total liabilities (Nkr33.19 Million). Check ULTI intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ultimovacs ASA Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Ultimovacs ASA across 9 annual periods. For the full cash flow conversion analysis, see Ultimovacs ASA cash flow conversion.
Annual Financial Flexibility Index for Ultimovacs ASA (2016–2024)
Year-by-year free cash flow to debt coverage for Ultimovacs ASA. Explore ULTI debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.92x | Nkr-163.39 Million | Nkr-163.40 Million | Nkr33.19 Million | ▼ -80.6% |
| 2023 | -2.73x | Nkr-189.80 Million | Nkr-189.83 Million | Nkr69.65 Million | ▲ +1.9% |
| 2022 | -2.78x | Nkr-167.50 Million | Nkr-167.69 Million | Nkr60.32 Million | ▼ -37.8% |
| 2021 | -2.02x | Nkr-125.74 Million | Nkr-125.83 Million | Nkr62.38 Million | ▲ +22.8% |
| 2020 | -2.61x | Nkr-107.94 Million | Nkr-108.22 Million | Nkr41.34 Million | ▼ -38.9% |
| 2019 | -1.88x | Nkr-62.82 Million | Nkr-62.99 Million | Nkr33.41 Million | ▼ -12.9% |
| 2018 | -1.66x | Nkr-49.88 Million | Nkr-50.39 Million | Nkr29.96 Million | ▲ +24.4% |
| 2017 | -2.20x | Nkr-27.20 Million | Nkr-27.23 Million | Nkr12.35 Million | ▲ +50.5% |
| 2016 | -4.45x | Nkr-30.31 Million | Nkr-31.10 Million | Nkr6.81 Million | — |